Altman: OpenAI IPO 'Ill-Advised' in 2026 | AI Valuations
Sam Altman calls an OpenAI IPO in 2026 'ill-advised' amid rising AI safety concerns. Learn what this signals for private-market AI valuations and investors.
Editorial7 min read
Iran's Hormuz Leverage and What It Means for Oil Prices
Iran's Hormuz reopening conditions and Houthi Red Sea gains are rattling oil markets. Here's what the escalating supply risk means for crude prices in 2026.
Editorial6 min read
Big Pharma's Cardiac Market Is Losing Its Profit Edge
Heart disease remains the world's top killer, yet big pharma's cardiovascular drug revenue is fading fast. Here's why Wall Street is taking notice.
Editorial7 min read
Ellison Cancels $7.5B Oracle Stock Sale: What It Means
Larry Ellison scrapped a plan to sell 50 million Oracle shares worth $7.5 billion. Discover what this reversal signals for Oracle investors and ORCL stock.
Editorial6 min read